Recent evidence has shown increased expression of SIGLEC10 and decreased expression of crystallin mu (CRYM) in the blood of Alzheimer’s disease patients, with both genes showing potential as diagnostic biomarkers [46]. This evidence concerns the gene CRYM and Alzheimer disease.